CJEU issues clarification on UK’s pay-for-delay generics ruling

The Court of Justice of the European Union (CJEU) has ruled that pharmaceutical pay-for-delay agreements may violate the Treaty on the Functioning of the European Union (TFEU), in comments passed down on January 30, 2020.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

Big Pharma

Retirees interest group supports California’s pay-for-delay ban

10 March 2020 The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements.

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

More on this story

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

Big Pharma

Retirees interest group supports California’s pay-for-delay ban

10 March 2020 The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements.

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

More on this story

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

Big Pharma

Retirees interest group supports California’s pay-for-delay ban

10 March 2020 The AARP has urged the US Court of Appeals for the Ninth Circuit to uphold a newly-formed California law prohibiting the majority of pay-for-delay pharmaceutical settlements.

Big Pharma

AG advises CJEU to uphold €94 million pay-for-delay fine

5 June 2020 The advocate general has recommended that the Court of Justice of the European Union uphold an almost €94 million fine imposed on Lundbeck for its pay-for-delay scheme.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

CJEU issues clarification on UK’s pay-for-delay generics ruling

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features